You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽託生物(300583.SZ)子公司斯瑞藥業完成變更公司名稱及經營範圍
格隆匯 12-26 21:57

格隆匯12月26日丨賽託生物(300583.SZ)公佈,公司於近日接到控股子公司山東斯瑞藥業有限公司(“斯瑞藥業”)的通知,因業務發展需要斯瑞藥業對名稱和經營範圍進行了變更,目前已完成相關工商變更登記手續及《公司章程》備案手續,並取得由菏澤市行政審批服務局核准換髮的《營業執照》。

1、公司名稱變更

變更前:山東斯瑞生物醫藥有限公司;變更後:山東斯瑞藥業有限公司

2、經營範圍變更

變更前經營範圍:21-羥基孕甾-1,4,9(11),16-四烯-3,20-二酮-21-醋酸酯(3-TR)、甲羥環氧孕酮(8-DM)、4-孕甾烯-17α,21-二醇-3,20-二酮-21-醋酸酯醫藥中間體、酸脱物(19-去甲基AD)、鹼脱物、米非司酮中間體、四九物的生產和銷售。(依法須經批准的項目,經相關部門批准後方可開展經營活動)

變更後經營範圍:21-羥基孕甾-1,4,9(11),16-四烯-3,20-二酮-21-醋酸酯(3-TR)、甲羥環氧孕酮(8-DM)、4-孕甾烯-17α,21-二醇-3,20-二酮-21-醋酸酯醫藥中間體、酸脱物(19-去甲基AD)、鹼脱物、米非司酮中間體、四九物的生產和銷售,原料藥的生產和銷售。(取得相關許可或備案後開展經營)(依法須經批准的項目,經相關部門批准後方可開展經營活動)

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account